Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Patricia Meaney who wrote (117801)	8/6/2003 4:38:57 PM
From: Patricia Meaney	Read Replies (1) \| Respond to of 150070

Also from their website, an update to shareholders: Dear Investor, It’s now official. We have received the approved contract with the Commonwealth of Kentucky Governor’s Office for Technology (GOT) to develop and test our provisionally-patented Verified Prescription SafeguardsTM System in a two-county pilot project through a grant from the Harold Rogers Prescription Drug Diversion Monitoring Fund of the U.S. Department of Justice Bureau of Justice Assistance. From this point forward, any public statements we make regarding the pilot must be approved by GOT, and will be issued as a news release. As such, you should not expect any regular “fireside chats” in this space. Please refer to our “In the News” page for any relevant updates as they are available. And please do not consider the lack of news a sign of no progress. We are now in a delicate and fundamental stage of our business plan. The successful outcome of the pilot is critical to our success, and we will do nothing to jeopardize this stage. This has been a long road, but many more milestones lie ahead until we reach our goal. We thank each and every one of our loyal and supportive shareholders who have kept the faith, stayed the course, and — we firmly believe — will be justly and amply rewarded. Very best regards, Best wishes, James Kemper Millard President & Chief Executive Officer Equity Technologies & Resources, Inc. 325 West Main Street, Suite 240 Post Office Box 12012 Lexington, Kentucky 40579 VOX: 859.268.4446 eFAX: 419.821.3646 This communication may contain forward-looking statements. The Company expressly disclaims any intent or obligation to update any forward-looking statements. Verified Prescription Safeguards, VeriScrip, and VPS are trademarks of Verified Prescription Safeguards, Inc., a wholly owned subsidiary of Equity Technologies & Resources, Inc. Envoii is a trademark of Envoii, Inc.